Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan

Oncogene
L CalvetGilles Vassal

Abstract

In vivo neuroblastoma (NB) xenograft model, resistant to the DNA-topoisomerase I inhibitor irinotecan (CPT-11), has been established to study resistance mechanisms acquired in a therapeutic setting. Common mechanisms of resistance were not involved in this resistance. Thus, we compared the gene expression profiles of sensitive, resistant, and reverted tumors using cDNA expression arrays. Expression of selected transcripts was confirmed by quantitative real-time PCR. We found that pleiotrophin (PTN), a heparin-binding growth factor, was the only gene significantly affected: PTN gene expression was downregulated in all resistant tumors (8-14-fold) as compared to sensitive tumors, and was increased (2-4-fold) in all reverted tumors as compared to resistant tumors. PTN thus appeared to be a likely candidate gene associated with resistance to CPT-11 in this in vivo model. To investigate the direct implication of PTN in NB, we transfected two NB cell lines with RNA interferences in order to silence PTN. PTN failed to demonstrate implication in resistance to CPT-11 in vitro but could influence sensitivity to CPT-11 exclusively through an in vivo mechanism. Indeed, vasculature was significantly enhanced in resistant NB xenografts compa...Continue Reading

References

Oct 15, 1991·Biochemical and Biophysical Research Communications·J CourtyD Barritault
Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A T LookG M Brodeur
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C T FongG M Brodeur
Dec 29, 1989·Biochemical and Biophysical Research Communications·P G MilnerT F Deuel
Sep 20, 1989·Journal of the National Cancer Institute·J BourhisG Riou
Mar 1, 1995·Cell Transplantation·J RozgaA A Demetriou
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A K ChauhanT F Deuel
May 1, 1996·Molecular Medicine Today·C Featherstone
Jan 1, 1996·Cancer Treatment and Research·E H RubinL F Liu
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·F CzubaykoA Wellstein
Dec 13, 1996·Annals of the New York Academy of Sciences·X G LiE H Rubin
Apr 1, 1997·Anti-cancer Drugs·J ThompsonP J Houghton
Sep 26, 1997·The Journal of Biological Chemistry·M J Corbley
Mar 28, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VassalA Gouyette
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W L FurmanP J Houghton
Sep 6, 2000·Nature Medicine·C A SchmittS W Lowe
Mar 27, 2001·Biochemical and Biophysical Research Communications·E PapadimitriouP Katsoris
Feb 14, 2002·Archives of Biochemistry and Biophysics·Thomas F DeuelZhao-Yi Wang
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Jul 11, 2002·The Journal of Biological Chemistry·Emma T BowdenAnton Wellstein
Mar 13, 2003·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·Nga Tran KimMichel Coster
Jun 12, 2003·British Journal of Cancer·H WildiersA T van Oosterom
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gilles VassalFrancois Pein
Oct 21, 2003·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Nicolas EliePaulette Herlin
Mar 12, 2004·Cancer Letters·Kenji Kadomatsu, Takashi Muramatsu
Jun 19, 2004·The International Journal of Biochemistry & Cell Biology·Apostolos PolykratisPanagiotis Katsoris

❮ Previous
Next ❯

Citations

Apr 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Christo BuizertEdward J Brook
Aug 11, 2012·Science·Peter U Clark
Mar 12, 2009·Expert Review of Anticancer Therapy·Thomas R WebbStephan W Morris
Jul 29, 2008·Connective Tissue Research·Constantinos Mikelis, Evangelia Papadimitriou
Sep 25, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gilles VassalBruce Morland
Sep 21, 2007·European Journal of Cell Biology·Anastasia ParthymouEvangelia Papadimitriou
Dec 3, 2014·Injury·Margarita LamprouEvangelia Papadimitriou
Oct 25, 2016·Biochimica Et Biophysica Acta·Evangelia PapadimitriouDimitris Beis
Feb 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Alexandre LabicheNicolas Elie
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·André OberthuerMatthias Fischer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.